南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

热亡细胞诱导的纳米载体通过调控热亡抗原释放与内源性免疫激活,增强肿瘤免疫治疗效果

Pyroptosis‐Amplified Decoy Nanovesicles Orchestrate Pyroptotic Antigen Explosion and Endogenous Immune Revitalization for Potentiating Tumour Immunotherapy

Geng Dou, Jiani Liu, Ran Tian, Keying Zhang, Meng Suo, Ding Zhou, Yipeng Zhang, Xuemei Liu, Xinyu Qiu, Jinxin Kuang, Zhaonan Zou, Shuchang Wang, Lu Zhao, Feng Ding, Di Wang, Congcong Guan, Xiaoyu Zhu

Journal:Journal of Extracellular Vesicles

IF:21.7

DOI:10.1002/jev2.70356

PMID:42661498

Published:2026-08-28

research field:

Abstract

Current advances in tumour immunotherapy remain constrained by inadequate cytotoxic T lymphocyte activation and the immunosuppressive tumour microenvironment. Innovative strategies are urgently required to enhance anti‐tumour immune potency for clinical improvements in immunotherapy‐resistant malignancies. Herein, we developed pyroptosis‐amplified decoy nanovesicles (PADVs) to synergistically dismantle tumour resistance mechanisms and rejuvenate endogenous anti‐tumour immunity. PADVs integrate checkpoint‐neutralizing capability with precise regulation of the pyroptosis molecular switch in tumour cells, thereby initiating a sequential activation cascade that enables efficient presentation of tumour‐specific antigens to the reshaped immune system. Systemically infused PADVs demonstrated dual‐targeting priority towards lymph node and deep tumour tissues, reversing immunosuppression through competitive blockade of PD‐1/PD‐L1 and SIRPα/CD47 axes while providing co‐stimulatory signals for immune reactivation. Furthermore, PADVs alleviate the epigenetic suppression of pyroptosis in tumours via cytosolic delivery of decitabine and LPS, enabling gasdermin D (GSDMD) upregulation and cleavage. This coordinated strategy reverses T cell exhaustion and triggers explosive antigen release via GSDMD‐mediated membrane perforation, initiating a self‐amplifying immune cascade involving dendritic cell activation, effector and memory T cell formation. Consequently, PADVs demonstrate excellent efficacy in suppressing tumour progression, recurrence, and metastasis in melanoma, breast cancer, and colon cancer models. This study pioneers a versatile nanoplatform that not only counteracts tumour immune evasion but also establishes durable anti‐tumour immunity, offering a transformative approach to tumour immunotherapy.

本文使用的Yeasen产品

购物车
客服
转染试用